China study of 670 SpA pts rx w/ sulfasalazine betw 2016 to 2023 (469 pure AS; 201 w/ peripheral Sxs). SSZ Signif. reduced peripheral Sxs development (HR 0.49) and improved disease activity in both pure axial and axial-with-peripheral Sxs. https://t.co/5HdQCos9yM https://t.co/tTMScQDHBq
Links:
Does Sulfasalazine Still Have Therapeutic Value in the Treatment of Axial Spond…
https://buff.ly/iV1Xx9v
29-08-2025
